Search research articles
Contact Us
Filters
Showing results (221-230 of 359) with videos related to
Page
of 36
Sort By:
Journal of the Neurological Sciences
|
June 6, 2013
Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity
A Waschbisch, M Atiya, C Schaub, et al.
Journal of Neuroinflammation
|
September 14, 2017
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
Anna Hammer, Anne Schliep, Stefanie Jörg, et al.
Journal of Neuroimmunology
|
October 28, 2008
IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier
Ralf A Linker, Fred Lühder, Karl-Josef Kallen, et al.
Muscle & Nerve
|
May 13, 2014
C9ORF72-ALS: P62- and ubiquitin-aggregation pathology in skeletal muscle
Matthias Türk, Gerrit Haaker, Lilli Winter, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
June 28, 2020
Neuromonitoring Using Neurosonography and Pupillometry in A Weaning and Early Neurorehabilitation Unit
Bernhard M Siepen, Stephan Grubwinkler, Andrea Wagner, et al.
Neuropathology and Applied Neurobiology
|
July 13, 2010
Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology
D-H Lee, I Metz, A Berthele, et al.
Archives of Neurology
|
June 12, 2013
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply
Ingo Kleiter, Kerstin Hellwig, Achim Berthele, et al.
Experimental Neurology
|
September 3, 2016
Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease
Christiane Reick, Gisa Ellrichmann, Teresa Tsai, et al.
Acta Neuropathologica
|
October 20, 2011
Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination
De-Hyung Lee, Eva Geyer, Anne-Christine Flach, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 2004
Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule
Lloyd E Damon, Laura J Johnston, Curt A Ries, et al.
Page
of 36
Search research articles
Search
Showing results (221-230 of 359) with videos related to
Sort By:
Page
of 36
Journal of the Neurological Sciences
|
June 6, 2013
Aquaporin-4 antibody negative recurrent isolated optic neuritis: clinical evidence for disease heterogeneity
A Waschbisch, M Atiya, C Schaub, et al.
Journal of Neuroinflammation
|
September 14, 2017
Impact of combined sodium chloride and saturated long-chain fatty acid challenge on the differentiation of T helper cells in neuroinflammation
Anna Hammer, Anne Schliep, Stefanie Jörg, et al.
Journal of Neuroimmunology
|
October 28, 2008
IL-6 transsignalling modulates the early effector phase of EAE and targets the blood-brain barrier
Ralf A Linker, Fred Lühder, Karl-Josef Kallen, et al.
Muscle & Nerve
|
May 13, 2014
C9ORF72-ALS: P62- and ubiquitin-aggregation pathology in skeletal muscle
Matthias Türk, Gerrit Haaker, Lilli Winter, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging
|
June 28, 2020
Neuromonitoring Using Neurosonography and Pupillometry in A Weaning and Early Neurorehabilitation Unit
Bernhard M Siepen, Stephan Grubwinkler, Andrea Wagner, et al.
Neuropathology and Applied Neurobiology
|
July 13, 2010
Supraspinal demyelinating lesions in neuromyelitis optica display a typical astrocyte pathology
D-H Lee, I Metz, A Berthele, et al.
Archives of Neurology
|
June 12, 2013
Is It Too Early to Predict the Failure of Natalizumab in NMO?-Reply
Ingo Kleiter, Kerstin Hellwig, Achim Berthele, et al.
Experimental Neurology
|
September 3, 2016
Expression of brain-derived neurotrophic factor in astrocytes - Beneficial effects of glatiramer acetate in the R6/2 and YAC128 mouse models of Huntington's disease
Christiane Reick, Gisa Ellrichmann, Teresa Tsai, et al.
Acta Neuropathologica
|
October 20, 2011
Central nervous system rather than immune cell-derived BDNF mediates axonal protective effects early in autoimmune demyelination
De-Hyung Lee, Eva Geyer, Anne-Christine Flach, et al.
Cancer Chemotherapy and Pharmacology
|
May 13, 2004
Treatment of acute leukemia with idarubicin, etoposide and cytarabine (IDEA). A randomized study of etoposide schedule
Lloyd E Damon, Laura J Johnston, Curt A Ries, et al.
Page
of 36